Practical implementation of ADA/EASD consensus algorithm in patients with type 2 diabetes in Pakistan

Area of Science:

• Endocrinology
• Metabolic Diseases
• Pharmacotherapy

Background:

• Type 2 diabetes management requires effective glycemic control.
• Established guidelines aim to optimize treatment strategies.
• Insulin therapy is crucial for many patients with type 2 diabetes.

Purpose of the Study:

• To evaluate the effectiveness of the 2009 American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) consensus algorithm.
• To assess glycemic control in type 2 diabetes patients using insulin glargine.
• To determine the safety profile, specifically hypoglycemia risk, associated with this treatment approach.

Main Methods:

• A prospective, observational, open-label product registry study.
• Conducted across 38 sites in Pakistan from July 2011 to February 2014.
• Involved patients with uncontrolled type 2 diabetes initiated on or switched to insulin glargine, with measurements at baseline, 3, and 6 months.

Main Results:

• A total of 307 patients were included, with a mean age of 49.5 years and diabetes duration of 7.1 years.
• Significant reductions in fasting blood glucose and glycated hemoglobin (HbA1c) were observed from baseline to 6 months (p<0.01).
• 18 patients reported 41 hypoglycemic episodes; none were severe, and most were asymptomatic or symptomatic.

Conclusions:

• Adherence to ADA/EASD guidelines for insulin initiation and titration proved effective.
• Glycemic targets were achieved in patients with type 2 diabetes.
• The use of insulin glargine according to guidelines did not elevate the risk of hypoglycemia.